Tryptophan and depressive illness.
Plasma free tryptophan is significantly decreased in monopolar, depressed patients. No evidence was found to suggest that poor nutritional history prior to hospital admission was responsible for these low levels. Factors known to influence tryptophan-albumin binding in plasma, e.g. concentration of plasma proteins, albumin and non-esterified fatty acids, did not account for the low levels of free tryptophan in depressed patients. A significant decrease in plasma free tryptophan levels was found in perimenopausal but not in pre- or post-menopausal female controls. This mirrors the decrease in circulating oestrogens. Although exogenously administered oestrogens do not have any therapeutic efficacy in relieving mild residual depressive symptoms of lithium treated patients, they increased the levels of plasma free tryptophan. Clofibrate also displaces tryptophan from plasma protein binding sites in both depressed patients and controls. Utilization of the increased levels of plasma free tryptophan is reduced in depressed patients. A situation therefore exists in depressed patients where the plasma free tryptophan is not only reduced but also leaves the plasma less readily than in control subjects.
D001798:Blood Proteins / Q000032:analysis; D002986:Clinical Trials as Topic; D002994:Clofibrate / Q000627:therapeutic use; D003863:Depression / Q000097:blood* / Q000188:drug therapy; D004044:Dietary Proteins / Q000008:administration & dosage; D004311:Double-Blind Method; D004966:Estrogens, Conjugated (USP) / Q000627:therapeutic use; D005230:Fatty Acids, Nonesterified / Q000097:blood; D005260:Female; D006801:Humans; D008593:Menopause; D008875:Middle Aged; D011485:Protein Binding / Q000187:drug effects; D014364:Tryptophan / Q000097:blood*
D001798:Blood Proteins; D004044:Dietary Proteins; D004966:Estrogens, Conjugated (USP); D005230:Fatty Acids, Nonesterified; D014364:Tryptophan; D002994:Clofibrate